Logo (Pyridostigmine Logo)
Pyridostigmine Bromide Tablet
Product Images NDC 64980-220
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Pyridostigmine Bromide (NDC 64980-220). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Structure (Pyridostigmine Structre)
Label (Pyridostigmine30ct)
Rising NDC 64980-220-03 is an extended-release tablet containing 180mg of Pyridostigmine Bromide, manufactured by Centaur Pharmaceuticals Private Limited. These tablets are hygroscopic and should be kept in a place with the sealed gel enclosed. The pharmacist should dispense in this unit-of-use container at a temperature of 25°C 77 (excursions permitted to 156G - 30°C (59°F - 86°F)) at room temperature. The tablets are moisture-sensitive and should be stored in tightly closed, unvarnished areas with desiccants. The package contains 30 tablets with dimensions of 50 x 20 mm. Dosage instructions are available in the accompanying package insert. Distributed by Rising Pharmaceuticals, Inc., Saddle Brook, NJ 07663.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
